vs
费森尤斯医疗（FMS）与Smurfit Westrock（SW）财务数据对比。点击上方公司名可切换其他公司
Smurfit Westrock的季度营收约是费森尤斯医疗的1.4倍（$7.6B vs $5.5B），费森尤斯医疗净利率更高（7.9% vs 1.3%，领先6.7%），Smurfit Westrock同比增速更快（0.5% vs -0.3%）
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
Smurfit Westrock plc是总部位于爱尔兰都柏林的企业，核心业务为生产瓦楞包装及各类纸制包装产品，公司股票同时在纽约证券交易所和伦敦证券交易所挂牌上市。
FMS vs SW — 直观对比
营收规模更大
SW
是对方的1.4倍
$5.5B
营收增速更快
SW
高出0.8%
-0.3%
净利率更高
FMS
高出6.7%
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $7.6B |
| 净利润 | $434.2M | $97.0M |
| 毛利率 | 27.4% | 18.2% |
| 营业利润率 | 11.7% | 5.1% |
| 净利率 | 7.9% | 1.3% |
| 营收同比 | -0.3% | 0.5% |
| 净利润同比 | 240.4% | -33.6% |
| 每股收益（稀释后） | — | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMSSW
| Q4 25 | $5.5B | $7.6B | ||
| Q3 25 | — | $8.0B | ||
| Q2 25 | — | $7.9B | ||
| Q1 25 | — | $7.7B | ||
| Q4 24 | $5.5B | $7.5B | ||
| Q3 24 | — | $7.7B | ||
| Q2 24 | — | $3.0B | ||
| Q1 24 | — | $2.9B |
净利润FMSSW
| Q4 25 | $434.2M | $97.0M | ||
| Q3 25 | — | $246.0M | ||
| Q2 25 | — | $-28.0M | ||
| Q1 25 | — | $384.0M | ||
| Q4 24 | $127.6M | $146.0M | ||
| Q3 24 | — | $-150.0M | ||
| Q2 24 | — | $132.0M | ||
| Q1 24 | — | $191.0M |
毛利率FMSSW
| Q4 25 | 27.4% | 18.2% | ||
| Q3 25 | — | 19.6% | ||
| Q2 25 | — | 19.1% | ||
| Q1 25 | — | 20.6% | ||
| Q4 24 | 25.0% | 19.1% | ||
| Q3 24 | — | 17.6% | ||
| Q2 24 | — | 23.3% | ||
| Q1 24 | — | 24.2% |
营业利润率FMSSW
| Q4 25 | 11.7% | 5.1% | ||
| Q3 25 | — | 6.6% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 7.2% | ||
| Q4 24 | 5.1% | 5.3% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 10.5% |
净利率FMSSW
| Q4 25 | 7.9% | 1.3% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | -0.4% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | 2.3% | 1.9% | ||
| Q3 24 | — | -2.0% | ||
| Q2 24 | — | 4.4% | ||
| Q1 24 | — | 6.5% |
每股收益（稀释后）FMSSW
| Q4 25 | — | $0.18 | ||
| Q3 25 | — | $0.47 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $0.73 | ||
| Q4 24 | — | $-0.12 | ||
| Q3 24 | — | $-0.30 | ||
| Q2 24 | — | $0.51 | ||
| Q1 24 | — | $0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $892.0M |
| 总债务越低越好 | — | $13.4B |
| 股东权益账面价值 | $15.4B | $18.3B |
| 总资产 | $33.5B | $45.2B |
| 负债/权益比越低杠杆越低 | — | 0.73× |
8季度趋势，按日历期对齐
现金及短期投资FMSSW
| Q4 25 | $1.7B | $892.0M | ||
| Q3 25 | — | $851.0M | ||
| Q2 25 | — | $778.0M | ||
| Q1 25 | — | $797.0M | ||
| Q4 24 | $1.3B | $855.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $26.8K | ||
| Q1 24 | — | $108 |
总债务FMSSW
| Q4 25 | — | $13.4B | ||
| Q3 25 | — | $13.3B | ||
| Q2 25 | — | $13.3B | ||
| Q1 25 | — | $12.9B | ||
| Q4 24 | — | $12.5B | ||
| Q3 24 | — | $13.2B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FMSSW
| Q4 25 | $15.4B | $18.3B | ||
| Q3 25 | — | $18.4B | ||
| Q2 25 | — | $18.3B | ||
| Q1 25 | — | $17.9B | ||
| Q4 24 | $17.0B | $17.4B | ||
| Q3 24 | — | $18.0B | ||
| Q2 24 | — | $14.5K | ||
| Q1 24 | — | $108 |
总资产FMSSW
| Q4 25 | $33.5B | $45.2B | ||
| Q3 25 | — | $45.6B | ||
| Q2 25 | — | $45.7B | ||
| Q1 25 | — | $44.6B | ||
| Q4 24 | $36.3B | $43.8B | ||
| Q3 24 | — | $45.0B | ||
| Q2 24 | — | $26.8K | ||
| Q1 24 | — | $108 |
负债/权益比FMSSW
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 0.72× | ||
| Q4 24 | — | 0.72× | ||
| Q3 24 | — | 0.73× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.9B | $1.2B |
| 自由现金流经营现金流 - 资本支出 | — | $612.0M |
| 自由现金流率自由现金流/营收 | — | 8.1% |
| 资本支出强度资本支出/营收 | — | 7.7% |
| 现金转化率经营现金流/净利润 | 6.67× | 12.32× |
| 过去12个月自由现金流最近4个季度 | — | $1.2B |
8季度趋势，按日历期对齐
经营现金流FMSSW
| Q4 25 | $2.9B | $1.2B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $829.0M | ||
| Q1 25 | — | $235.0M | ||
| Q4 24 | $2.6B | $781.0M | ||
| Q3 24 | — | $320.0M | ||
| Q2 24 | — | $340.0M | ||
| Q1 24 | — | $42.0M |
自由现金流FMSSW
| Q4 25 | — | $612.0M | ||
| Q3 25 | — | $523.0M | ||
| Q2 25 | — | $307.0M | ||
| Q1 25 | — | $-242.0M | ||
| Q4 24 | — | $212.0M | ||
| Q3 24 | — | $-192.0M | ||
| Q2 24 | — | $163.0M | ||
| Q1 24 | — | $-166.0M |
自由现金流率FMSSW
| Q4 25 | — | 8.1% | ||
| Q3 25 | — | 6.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | -3.2% | ||
| Q4 24 | — | 2.8% | ||
| Q3 24 | — | -2.5% | ||
| Q2 24 | — | 5.5% | ||
| Q1 24 | — | -5.7% |
资本支出强度FMSSW
| Q4 25 | — | 7.7% | ||
| Q3 25 | — | 7.6% | ||
| Q2 25 | — | 6.6% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | — | 6.0% | ||
| Q1 24 | — | 7.1% |
现金转化率FMSSW
| Q4 25 | 6.67× | 12.32× | ||
| Q3 25 | — | 4.61× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.61× | ||
| Q4 24 | 20.20× | 5.35× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.58× | ||
| Q1 24 | — | 0.22× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FMS
暂无分部数据
SW
| Packaging | $3.3B | 43% |
| Other | $3.2B | 43% |
| Paper | $1.1B | 14% |
